Full-Time

QA Sr. Manager

Drug Product

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Senior

Norwood, MA, USA

70% in-office work model.

Category
QA & Testing
Quality Assurance
Requirements
  • Bachelor of Science degree in Engineering, Pharmaceutical Sciences, or a related technology discipline.
  • A minimum of 8 years of experience in aseptic drug product manufacturing.
  • Problem-solving mindset with a commitment to quality and safety.
  • In-depth knowledge of cGMP regulations, aseptic processing, and cleanroom operations.
  • Strong leadership skills with the ability to develop and motivate a diverse team.
  • Excellent project management, organizational, and communication skills.
  • Demonstrated ability to work cross-functionally and manage complex projects with multiple stakeholders, with the ability to convey complex information in an understandable manner to various stakeholders.
Responsibilities
  • Executing robust operational readiness plans to transition from the construction phase to full-scale production, ensuring all systems and processes are in place for cGMP compliance.
  • Execution of a project quality plan, paying key attention to the audit readiness components to ensure a successful pre-approval inspection.
  • Assist with the development and implementation of operational and quality systems (i.e. deviation / change management, batch record management, cleaning & disinfection, personnel training, etc.) ensuring Quality 4.0 / Pharma 4.0 principles are embedded into their design.
  • Collaborate with cross-functional teams working in a highly matrixed environment to drive decisions and influence outcomes to enable Moderna’s clinical pipeline.
  • Routinely identify and escalate project quality risks, and proposed resolution through governance channels, where needed.
  • Provide expert guidance and support while managing interfaces with key business stakeholders for quality and operational processes.
  • Work to ensure a ‘Right-First-Time’ and mature quality culture is developed and maintained within the project leading to a successful PAI outcome.
  • Support troubleshooting of complex issues encountered during CQV activities. In addition, provide support for CQV deviations and change management teams.
  • Ensure timely resolution and/or escalation of quality issues to senior management.
  • Ensure adherence to all environmental, health, and safety guidelines, promoting a culture of safety within the operations team.
  • Support the development of key performance indicators (KPIs) to measure and report on operational performance, making data-driven decisions to optimize processes.
  • Foster a culture of innovation and collaboration, encouraging team members to contribute ideas for process improvements and operational excellence.
  • Drive and/or support continuous improvement initiatives to enhance operational efficiency, reduce costs, and improve product quality.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?